百奥文图斯 BVS
$10.61 −$0.07 (-0.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.61 0.00%
开盘$10.41
昨收$10.68
当日区间$10.34 – $10.74
成交量642.5K
市值$726.51M
市盈率（TTM）13.1
股息率–
BVS 相关新闻
匹配 Bioventus 或代码 BVS 的头条新闻，按最新排序。
- CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 正面
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 正面
- Earnings Flash (BVS) Bioventus Inc. Posts Q2 Adjusted EPS $0.22 per Share, Vs. FactSet Est of $0.22
- J.P. Morgan Keeps Their Hold Rating on Bravura Solutions Limited (BVS)
- CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $19
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crinetics Pharmaceuticals (CRNX)
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $14
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $14 正面
- CJS Securities Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $14
- Barrington Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $13
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $18
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $15
暂无评论——快来第一个聊聊 BVS。